All Posts By

Smartkarma Daily Briefs

Daily Brief Japan: Kawasaki Heavy Industries, Ryohin Keikaku, Shibaura Electronics, Freee KK, Dentsu Inc, JFE Holdings, TSE Tokyo Price Index TOPIX and more

By | Daily Briefs, Japan

In today’s briefing:

  • [Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Kawasaki Heavy (7012 JP)
  • [Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Ryohin Keikaku (7453 JP)
  • Shibaura Electronics (6957 JP): Yageo Goes All in with a JPY6,635 Offer
  • 2025 High Conviction – Freee: 4Q Setback Is Only Temporary
  • Dentsu Group — Japan performs well, international tougher
  • JFE Holdings (5411 JP) – Soft Q1 Priced In; Compelling Upside from Lowest EV/Ton in Peers
  • Isn’t the Market Impatient for the Companies to Implement Management Reforms?


[Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Kawasaki Heavy (7012 JP)

By Travis Lundy

  • On 26 August at the close, 2 names will get added to and 5 names deleted from a global index provider’s major Japan/global “standard” index.
  • 6 of 7 changes were in the Quiddity Index predictions as of end Jun-2025. One dropped, then two got added. Our final predictions had all seven plus one more DEL.
  • These changes were well-flagged so well pre-positioned. This insight looks at shareholder structure, historical fundamental ratios, and performance vs Peers. Watch the direct peers.

[Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Ryohin Keikaku (7453 JP)

By Travis Lundy

  • On 26 August at the close, 2 names will get added to and 5 names deleted from a global index provider’s major Japan/global “standard” index.
  • 6 of 7 changes were in the Quiddity Index predictions as of end Jun-2025. One dropped, then two got added. Our final predictions had all seven plus one more DEL.
  • They were well-flagged so well pre-positioned. This insight looks at shareholder structure, historical fundamental ratios, and performance vs Peers. This sets up a possible trade before or into the event.

Shibaura Electronics (6957 JP): Yageo Goes All in with a JPY6,635 Offer

By Arun George

  • In response to Minebea Mitsumi (6479 JP) matching its Shibaura Electronics (6957 JP) offer on 14 August, Yageo Corporation (2327 TT) increased its offer by 7.0% from JPY6,200 to JPY6,635.  
  • To remain in the game, Yageo had to bump. The latest bump underscores Yageo’s confidence in securing regulatory approvals. 
  • The Minebea CEO suggested that its JPY6,200 offer would be the final one. If Yageo secures regulatory approval (likely), Minebea will walk rather than match Yageo’s latest offer. 

2025 High Conviction – Freee: 4Q Setback Is Only Temporary

By Shifara Samsudeen, FCMA, CGMA

  • Freee KK (4478 JP)  reported 4Q and full-year FY06/2025 results last week which disappointed the market leading to a sell-off.
  • After reporting 3-consecutive quarters of Adj. OP, profitability dipped in 4Q due to higher advertising and D&A costs. However, freee expects to return to profits in the current fiscal year. 
  • Following 4Q results, premium over Money Forward has disappeared and Freee is currently trading at a huge discount to MF which seems unwarranted

Dentsu Group — Japan performs well, international tougher

By Edison Investment Research

Dentsu’s Q225 performance was a little below management expectations, with conditions remaining challenging outside Japan. Group operating margins were controlled for H125 at 12.0%. With a further goodwill write-down of ¥86.0bn, Dentsu reported a statutory loss for H125 and is not now paying an interim dividend. A decision on the full year will be made later, and our model assumes dividends resume for FY26. Our FY25 forecasts have been realigned to match revised guidance, with a slightly more cautious stance on growth for FY26. Management’s target for operating margins of 16–17% by FY27 remains in place, predicated on the targeted cost reductions in the mid-term management plan.


JFE Holdings (5411 JP) – Soft Q1 Priced In; Compelling Upside from Lowest EV/Ton in Peers

By Rahul Jain

  • Q1 FY2025 was weak with Steel swinging to losses (–¥2,300/t) on spreads, FX, and inventory drag, leaving recovery hinging on H2.
  • We retain our FY25–28 earnings estimates, assuming stable ~15–16% EBITDA margins and volume growth to 31.6 Mt by FY28.
  • At ~US$525/t EV/t (adj.), JFE trades at a deep discount to Nippon Steel, but upside depends on spreads stabilizing and tariff risks not worsening.

Isn’t the Market Impatient for the Companies to Implement Management Reforms?

By Aki Matsumoto

  • More companies are mentioning share buybacks, reducing cross-shareholdings, capital allocation policies, and capital costs. However, the ROE of most companies has not improved significantly.
  • “TSE’s request” is at critical juncture addressing whether it’ll lead to formal improvements such as the introduction of corporate governance code, or whether it’ll enable sustainable growth in corporate value.
  • Looking at recent market trends, investors are increasingly expecting activist investors to directly demand management reforms from companies, in anticipation that it’ll take time to realize results of internal reforms.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Kawasaki Heavy Industries, Mangal Electrical Industries, Soilbuild Construction, bpost SA, Hesai Group, Lennox International and more

By | Daily Briefs, Industrials

In today’s briefing:

  • [Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Kawasaki Heavy (7012 JP)
  • Mangal Electrical IPO: A Strong Force in Transformer and Power Solutions?
  • SoilBuild Construction Group Limited: Soilbuild’s 1HFY25 Earnings Soar Past FY24
  • What’s News in Amsterdam – 21 August (Aegon | a.s.r. Nederland | dsm-firmenich | Alfen | bpostgroup)
  • [Hesai Group (HSAI US, BUY, TP US$35) Review]: Rapid Cost Down Continued Driving Penetration
  • Lennox’s $550 Million HVAC Play: What The NSI Industries Acquisition Could CHANGE For The Cooling Giant!


[Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Kawasaki Heavy (7012 JP)

By Travis Lundy

  • On 26 August at the close, 2 names will get added to and 5 names deleted from a global index provider’s major Japan/global “standard” index.
  • 6 of 7 changes were in the Quiddity Index predictions as of end Jun-2025. One dropped, then two got added. Our final predictions had all seven plus one more DEL.
  • These changes were well-flagged so well pre-positioned. This insight looks at shareholder structure, historical fundamental ratios, and performance vs Peers. Watch the direct peers.

Mangal Electrical IPO: A Strong Force in Transformer and Power Solutions?

By Nimish Maheshwari

  • MEIL is well-positioned for long-term growth due to its expertise in transformer components and EPC services, strong market presence, with a solid focus on India’s energy infrastructure development.
  • MEIL benefits from both backward and forward integration, enhancing operational efficiency and reducing raw material dependency. Its diversified customer base spans multiple sectors, reducing exposure to sector-specific risks.
  • MEIL’s has shown steady growth, driven by its core and EPC businesses. Despite risks like raw material volatility, the company is well-placed to capitalize on India’s growing power infrastructure demand.

SoilBuild Construction Group Limited: Soilbuild’s 1HFY25 Earnings Soar Past FY24

By SAC Capital

  • Soilbuild delivered a stellar financial performance in 1HFY25.
  • The Group’s 1HFY25 net profit surged 282.9% YoY to S$28.3 million, exceeding FY24 full year net profit of $26.6 million.
  • 1HFY25 revenue increased 77.3% YoY to S$272.8 million, while gross profit jumped 193.5% YoY to S$43.6 million, reflecting strong execution and margin improvements across both construction and precast operations.

What’s News in Amsterdam – 21 August (Aegon | a.s.r. Nederland | dsm-firmenich | Alfen | bpostgroup)

By The IDEA!

  • In today’s edition: • Aegon | 1H25 OCG looks a bit light; review to relocate legal domicile and head office to US • a.s.r. Nederland | post earnings call comment • dsm-firmenich | in exclusive talks with CVC on its AHN division; may keep minority stake • Alfen | reiterates FY25 guidance, however, revises FY26 ambition downward • bpostgroup | temporarily suspends individual parcel shipments to the US

[Hesai Group (HSAI US, BUY, TP US$35) Review]: Rapid Cost Down Continued Driving Penetration

By Eric Wen

  • HESAI (HSAI) reported C2Q25 top line, non-GAAP operating profit and GAAP net income in-line, 143% and 6019% vs. our estimate. 
  • ADS LiDAR shipment beat our estimate by 50%, growing 276% YoY and 108% QoQ; Robotic LiDAR grew 744% YoY and (2%) QoQ, beating our estimate by 32%; 
  • Despite the ASP erosion, gross margin grew 2.2ppt YoY and 0.9ppt QoQ to 42.5%, missing our estimate by 0.5ppt. We reiterate our TOP BUY and raise TP to US$35.

Lennox’s $550 Million HVAC Play: What The NSI Industries Acquisition Could CHANGE For The Cooling Giant!

By Baptista Research

  • Lennox International Inc.’s second quarter results provide a comprehensive view into the company’s operational dynamics amidst current market challenges.
  • The firm’s achievement of a 3% revenue growth and margin expansion to 23.6% indicates a robust performance driven by strategic product offerings, particularly the transition to low global warming potential (GWP) R-454B products.
  • This transition seems to have been majorly successful, with approximately 90% of Lennox’s sales now comprising R-454B refrigerant, enhancing product mix and overall profitability.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: Isn’t the Market Impatient for the Companies to Implement Management Reforms? and more

By | Daily Briefs, ESG

In today’s briefing:

  • Isn’t the Market Impatient for the Companies to Implement Management Reforms?


Isn’t the Market Impatient for the Companies to Implement Management Reforms?

By Aki Matsumoto

  • More companies are mentioning share buybacks, reducing cross-shareholdings, capital allocation policies, and capital costs. However, the ROE of most companies has not improved significantly.
  • “TSE’s request” is at critical juncture addressing whether it’ll lead to formal improvements such as the introduction of corporate governance code, or whether it’ll enable sustainable growth in corporate value.
  • Looking at recent market trends, investors are increasingly expecting activist investors to directly demand management reforms from companies, in anticipation that it’ll take time to realize results of internal reforms.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Shibaura Electronics, Fractal Analytics Ltd, Taiwan Semiconductor (TSMC) – ADR, iFAST, Kuaishou Technology, Intel Corp, Freee KK, Salesforce.Com Inc, Nazara Technologies and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Shibaura Electronics (6957 JP): Yageo Goes All in with a JPY6,635 Offer
  • Fractal Analytics Pre-IPO Tearsheet
  • TSMC (2330.TT; TSM.US): 2nm Production Schedule in US Could Be One Year Ahead of Previous Schedule.
  • iFAST Corporation Limited: Breaking Out
  • KS / Kuaishou (1024 HK): 2Q25, Op Profit Up by 35% YoY, 91% Upside
  • A Defining Bet: Intel’s New Capital and the Case for Buying a Stake in Taiwan’s UMC
  • 2025 High Conviction – Freee: 4Q Setback Is Only Temporary
  • Masa’s AI Double Down: Masterstroke or Misstep?
  • CRM US – Salesforce Bets On Agentic Automation: What The Regrello Acquisition Could Unlock!
  • Nazara Technologies in Turbulence: Temporary Setback or Lasting Damage?


Shibaura Electronics (6957 JP): Yageo Goes All in with a JPY6,635 Offer

By Arun George

  • In response to Minebea Mitsumi (6479 JP) matching its Shibaura Electronics (6957 JP) offer on 14 August, Yageo Corporation (2327 TT) increased its offer by 7.0% from JPY6,200 to JPY6,635.  
  • To remain in the game, Yageo had to bump. The latest bump underscores Yageo’s confidence in securing regulatory approvals. 
  • The Minebea CEO suggested that its JPY6,200 offer would be the final one. If Yageo secures regulatory approval (likely), Minebea will walk rather than match Yageo’s latest offer. 

Fractal Analytics Pre-IPO Tearsheet

By Akshat Shah

  • Fractal Analytics Ltd (2453623D IN) is looking to raise about US$560m in its upcoming India IPO. The deal will be run by Axis, GS, MS and Kotak.
  • Fractal Analytics Limited is an enterprise artificial intelligence (AI) company which supports large global enterprises with data-driven insights and assists them in their decision making through its end-to-end AI solutions.
  • According to the Everest Report, FAL was India’s leading pure-play enterprise data, analytics and AI company, recognized globally, with capabilities across the data, analytics and AI (DAAI) value chain.

TSMC (2330.TT; TSM.US): 2nm Production Schedule in US Could Be One Year Ahead of Previous Schedule.

By Patrick Liao

  • TSMC Chairman C.C. Wei previously emphasized that customer demand for 2nm technology surpasses that for 3nm, and the company is actively working to expand production capacity. 
  • For 2nm technology, we expect production to take place at the Tainan fab, ahead of the U.S. Arizona fab and earlier than the previously anticipated 2028 timeline.
  • Taiwan Semiconductor (TSMC) – ADR (TSM US)’s next generation 2nm development is actively progressing.

iFAST Corporation Limited: Breaking Out

By GEMS Research – Aletheia Capital

  • IFAST SP has risen 28% since our initiation and has seen net institutional outflows of S$50m in the first week of the month.
  • We see further upside of 12%, as the value in terms of P/AUM is not reflected in the price.
  • Recent private transactions such as the Chocolate Finance Series A+ deal round indicate that iFAST is cheap relative to its assets. There is a strong chance of a buy back in 2026.

KS / Kuaishou (1024 HK): 2Q25, Op Profit Up by 35% YoY, 91% Upside

By Ming Lu

  • The growth rate of GMV (Gross Merchandise Value) rose to 18% YoY in 2Q25 from 15% YoY in 1Q25.
  • The operating margin improved to 13% in 2Q25 from 11% in 2Q24 so that operating profit increased by 35% YoY in 2Q25.
  • We conclude an stock upside of 91% for the next twelve months. Buy.

A Defining Bet: Intel’s New Capital and the Case for Buying a Stake in Taiwan’s UMC

By Vincent Fernando, CFA

  • A major Intel balance sheet boost, backed by SoftBank, the U.S. government, and leading institutions, would enhance the company’s capacity to make bold bets on regaining global chip manufacturing leadership.
  • UMC’s market valuation is less than the capex for just one advanced fab. Intel would likely make a gain on its investment since it would cause UMC shares to rally.
  • For less than the cost of a single advanced fab, a large company could acquire UMC and gain chipmaking expertise approaching TSMC’s level; boosting returns across an entire fab network.

2025 High Conviction – Freee: 4Q Setback Is Only Temporary

By Shifara Samsudeen, FCMA, CGMA

  • Freee KK (4478 JP)  reported 4Q and full-year FY06/2025 results last week which disappointed the market leading to a sell-off.
  • After reporting 3-consecutive quarters of Adj. OP, profitability dipped in 4Q due to higher advertising and D&A costs. However, freee expects to return to profits in the current fiscal year. 
  • Following 4Q results, premium over Money Forward has disappeared and Freee is currently trading at a huge discount to MF which seems unwarranted

Masa’s AI Double Down: Masterstroke or Misstep?

By Raghav Vashisht

  • SoftBank widens its AI bet with a $2B stake in Intel, suffers a 12% dip over two consecutive days.
  • Nvidia’s dominance has hyperscalers wary of lock-in. With Amazon and Microsoft building their chips, SoftBank’s move lands right as the market searches for alternatives.
  • Can Son replicate Intel’s historic design-fab alignment in AI, or would execution risk outweigh his ecosystem-diversification logic?

CRM US – Salesforce Bets On Agentic Automation: What The Regrello Acquisition Could Unlock!

By Baptista Research

  • Salesforce is charging deeper into the AI frontier.
  • On August 18, 2025, the CRM titan announced a definitive agreement to acquire Regrello, an AI-native startup that specializes in transforming fragmented business processes into orchestrated, automated workflows.
  • The deal, expected to close in Salesforce’s fiscal Q3 2026, underscores the company’s commitment to building out its “agentic enterprise” vision—where human workers and AI agents collaborate in real time.

Nazara Technologies in Turbulence: Temporary Setback or Lasting Damage?

By Sudarshan Bhandari

  • The Lok Sabha passed the Online Gaming Bill, 2025, banning all RMG platforms and putting Nazara’s PokerBaazi investment at significant risk.
  • While Nazara has no direct RMG exposure, its INR 805 crore PokerBaazi bet could turn worthless, raising concerns over capital allocation and valuation pressure. 
  • Core businesses remain strong, but regulatory uncertainty warrants caution. Near-term downside risks persist; long-term clarity hinges on execution and policy direction. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Energy/Materials: Mosaic Co/The, Jiaxin International Resources Investment Limited, Lumax Auto Technologies, Iron Ore, Schlumberger Ltd, JFE Holdings, Westlake Chemical, Panoro Energy ASA, Santacruz Silver Mining, SGX Rubber Future TSR20 and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • The Mosaic Company: Riding The Fertilizer Boom With Pricing Power & Market Edge!
  • Jiaxin International Resources Investment IPO – No Track Record, Government Supported
  • The Beat Ideas: Lumax Auto Technologies – Accelerating Ahead with the 20.20.20.20 Strategy
  • [IO Technicals 2025/34] Iron Ore Braces for Bullish Shift After Six-Day Slide
  • The Equity Dispatch #48: SLB: Papering Over the Problems Is Making Them Worse
  • JFE Holdings (5411 JP) – Soft Q1 Priced In; Compelling Upside from Lowest EV/Ton in Peers
  • Westlake Corporation Is Riding The Infrastructure Boom — Can Water Products Secure Long-Term Growth?
  • Panoro Energy ASA (OSE: PEN): Large cash build-up expected in 2H25
  • SCZ: Another Quarter of Strong Cashflow & Lower Costs
  • Deals, Recycling, Research And AI Power Thailand’s Rubber Shift


The Mosaic Company: Riding The Fertilizer Boom With Pricing Power & Market Edge!

By Baptista Research

  • The Mosaic Company recently shared its financial results for the second quarter of 2025, showcasing a mixed performance largely characterized by operational challenges but an optimistic future outlook.
  • The company’s efforts to enhance operating efficiencies and asset reliability are starting to bear fruit, though certain operational interruptions have impacted short-term outcomes, particularly in the phosphates segment.
  • For the quarter, The Mosaic Company reported net income of $411 million, a significant turnaround from last year’s net loss of $162 million.

Jiaxin International Resources Investment IPO – No Track Record, Government Supported

By Sumeet Singh

  • Jiaxin International Resources Investment Limited (JIRI) is looking to raise around US$153m in its upcoming Hong Kong IPO.
  • Jiaxin International owns exclusive rights to a globally significant tungsten asset, supported by Jiangxi Copper. Commercial production began in April 2025, with full ramp-up expected by 2027.
  • We have looked at the company’s background in our earlier note, in this note we talk about the deal pricing.

The Beat Ideas: Lumax Auto Technologies – Accelerating Ahead with the 20.20.20.20 Strategy

By Sudarshan Bhandari

  • Lumax’s strong product portfolio, global partnerships, and 80% market share in key segments position it as a dominant player in India’s automotive component industry.
  • Lumax’s strategic acquisitions, including IAC India and GreenFuel Mobility, and the “NorthStar Strategy” aim to drive revenue growth, operating margins, and leadership in clean mobility solutions.
  • Lumax’s SHIFT project enable technological integration, enhancing product offerings and content per vehicle, positioning LATL for long-term growth in the automotive market.

[IO Technicals 2025/34] Iron Ore Braces for Bullish Shift After Six-Day Slide

By Umang Agrawal

  • Iron ore drops on Tangshan curbs, but stable hot metal output underpins near-term price support. 
  • Managed money participants remain net long in iron ore, but softer buying momentum signalled profit-taking.  
  • Mean reversion and bullish MA crossover signal upside potential for the 62%/65% spread. 

The Equity Dispatch #48: SLB: Papering Over the Problems Is Making Them Worse

By J Capital Research

  • Since our last newsletter addressing concerns about Schlumberger NV (SLB) dated in October of 2023, the company’s share price has fallen by 41% on an absolute basis, while the S&P 500 is up 50.4% over the same period.
  • For a company with a market capitalization of $49.2 bln, this is significant.
  • Our primary concerns were that SLB had potential write offs related to outstanding receivables from its Mexican PEMEX customer as well as continued exposure to Russia.

JFE Holdings (5411 JP) – Soft Q1 Priced In; Compelling Upside from Lowest EV/Ton in Peers

By Rahul Jain

  • Q1 FY2025 was weak with Steel swinging to losses (–¥2,300/t) on spreads, FX, and inventory drag, leaving recovery hinging on H2.
  • We retain our FY25–28 earnings estimates, assuming stable ~15–16% EBITDA margins and volume growth to 31.6 Mt by FY28.
  • At ~US$525/t EV/t (adj.), JFE trades at a deep discount to Nippon Steel, but upside depends on spreads stabilizing and tariff risks not worsening.

Westlake Corporation Is Riding The Infrastructure Boom — Can Water Products Secure Long-Term Growth?

By Baptista Research

  • Westlake Corporation’s second-quarter 2025 performance reveals a complex interplay of factors impacting its two primary segments: Housing and Infrastructure Products (HIP) and Performance and Essential Materials (PEM).
  • In the HIP segment, Westlake experienced an uptick in performance, reflecting solid EBITDA of $275 million on sales of $1.2 billion, which translates to a strong margin of 24%.
  • This was fueled by increased demand for pipe and fittings, particularly in municipal water infrastructure, supported partly by the 2021 Infrastructure Act.

Panoro Energy ASA (OSE: PEN): Large cash build-up expected in 2H25

By Auctus Advisors

  • • 2Q25 production of 11,064 bbl/d had already been reported.
  • The production was impacted by unplanned downtime at Ceiba (~5,000 bbl/d gross or ~700 bbl/d net to Panoro’s 14.25% WI).
  • Remedial works are expected to restore production in 4Q25.

SCZ: Another Quarter of Strong Cashflow & Lower Costs

By Atrium Research

  • What you need to know: • Santacruz reported Q2 revenue of $73.3M (+4% YoY) vs. our estimate of $72.1M on a 15% decline in produced ounces.
  • • However, cost reduction was a theme for the quarter, with cash costs coming in at $19.48/oz vs. our estimate of $22.6/oz.
  • This led to adjusted EBITDA of $26.8M compared to our estimate of $21.0M and $16.0M reported in Q2/24.

Deals, Recycling, Research And AI Power Thailand’s Rubber Shift

By Vinod Nedumudy

  • Bridgestone reshapes carbon black strategy with Tokai Carbon  
  • Hanwa invests in Thai tyre pyrolysis venture  
  • Sri Trang bets on AI and workforce upskilling

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Quantitative Analysis: ASX Short Interest Weekly (Aug 15th): Liontown Resources and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • ASX Short Interest Weekly (Aug 15th): Liontown Resources, CAR, ANZ, Light & Wonder


ASX Short Interest Weekly (Aug 15th): Liontown Resources, CAR, ANZ, Light & Wonder

By Ke Yan, CFA, FRM

  • We analyzed the changes in short interest of ASX Stocks as of Aug 15th (reported today). The aggregated short interest was USD26.2bn.
  • We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases & decreases in short value, short as multiple of ADT.
  • We highlight short interest changes in Liontown Resources, CAR, ANZ, Light & Wonder, Premier Investments.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Kawasaki Heavy Industries, Mangal Electrical Industries, Soilbuild Construction, bpost SA, Hesai Group, Lennox International and more

By | Daily Briefs, Industrials

In today’s briefing:

  • [Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Kawasaki Heavy (7012 JP)
  • Mangal Electrical IPO: A Strong Force in Transformer and Power Solutions?
  • SoilBuild Construction Group Limited: Soilbuild’s 1HFY25 Earnings Soar Past FY24
  • What’s News in Amsterdam – 21 August (Aegon | a.s.r. Nederland | dsm-firmenich | Alfen | bpostgroup)
  • [Hesai Group (HSAI US, BUY, TP US$35) Review]: Rapid Cost Down Continued Driving Penetration
  • Lennox’s $550 Million HVAC Play: What The NSI Industries Acquisition Could CHANGE For The Cooling Giant!


[Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Kawasaki Heavy (7012 JP)

By Travis Lundy

  • On 26 August at the close, 2 names will get added to and 5 names deleted from a global index provider’s major Japan/global “standard” index.
  • 6 of 7 changes were in the Quiddity Index predictions as of end Jun-2025. One dropped, then two got added. Our final predictions had all seven plus one more DEL.
  • These changes were well-flagged so well pre-positioned. This insight looks at shareholder structure, historical fundamental ratios, and performance vs Peers. Watch the direct peers.

Mangal Electrical IPO: A Strong Force in Transformer and Power Solutions?

By Nimish Maheshwari

  • MEIL is well-positioned for long-term growth due to its expertise in transformer components and EPC services, strong market presence, with a solid focus on India’s energy infrastructure development.
  • MEIL benefits from both backward and forward integration, enhancing operational efficiency and reducing raw material dependency. Its diversified customer base spans multiple sectors, reducing exposure to sector-specific risks.
  • MEIL’s has shown steady growth, driven by its core and EPC businesses. Despite risks like raw material volatility, the company is well-placed to capitalize on India’s growing power infrastructure demand.

SoilBuild Construction Group Limited: Soilbuild’s 1HFY25 Earnings Soar Past FY24

By SAC Capital

  • Soilbuild delivered a stellar financial performance in 1HFY25.
  • The Group’s 1HFY25 net profit surged 282.9% YoY to S$28.3 million, exceeding FY24 full year net profit of $26.6 million.
  • 1HFY25 revenue increased 77.3% YoY to S$272.8 million, while gross profit jumped 193.5% YoY to S$43.6 million, reflecting strong execution and margin improvements across both construction and precast operations.

What’s News in Amsterdam – 21 August (Aegon | a.s.r. Nederland | dsm-firmenich | Alfen | bpostgroup)

By The IDEA!

  • In today’s edition: • Aegon | 1H25 OCG looks a bit light; review to relocate legal domicile and head office to US • a.s.r. Nederland | post earnings call comment • dsm-firmenich | in exclusive talks with CVC on its AHN division; may keep minority stake • Alfen | reiterates FY25 guidance, however, revises FY26 ambition downward • bpostgroup | temporarily suspends individual parcel shipments to the US

[Hesai Group (HSAI US, BUY, TP US$35) Review]: Rapid Cost Down Continued Driving Penetration

By Eric Wen

  • HESAI (HSAI) reported C2Q25 top line, non-GAAP operating profit and GAAP net income in-line, 143% and 6019% vs. our estimate. 
  • ADS LiDAR shipment beat our estimate by 50%, growing 276% YoY and 108% QoQ; Robotic LiDAR grew 744% YoY and (2%) QoQ, beating our estimate by 32%; 
  • Despite the ASP erosion, gross margin grew 2.2ppt YoY and 0.9ppt QoQ to 42.5%, missing our estimate by 0.5ppt. We reiterate our TOP BUY and raise TP to US$35.

Lennox’s $550 Million HVAC Play: What The NSI Industries Acquisition Could CHANGE For The Cooling Giant!

By Baptista Research

  • Lennox International Inc.’s second quarter results provide a comprehensive view into the company’s operational dynamics amidst current market challenges.
  • The firm’s achievement of a 3% revenue growth and margin expansion to 23.6% indicates a robust performance driven by strategic product offerings, particularly the transition to low global warming potential (GWP) R-454B products.
  • This transition seems to have been majorly successful, with approximately 90% of Lennox’s sales now comprising R-454B refrigerant, enhancing product mix and overall profitability.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Japanese Retailer Red Alert Is the Reddest Ever and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Japanese Retailer Red Alert Is the Reddest Ever
  • GAME OVER: Inside India’s Real Money Gaming Ban
  • Exencial Industry Tidings 21/08/2025


Japanese Retailer Red Alert Is the Reddest Ever

By Michael Allen

  • Japan maybe facing an unprecedented heat wave this fall, threatening retailers’ profits as high-end seasonal items may not sell 
  • Six major retailers, including Fast Retailing, are at risk of serious profit declines if the weather forecasts are accurate. That’s a big “IF”, but wait, there’s more.
  • U.S. tariffs on clothing could devastate Fast Retailing’s profits there, potentially forcing them to withdraw from the U.S. market.  

GAME OVER: Inside India’s Real Money Gaming Ban

By Nimish Maheshwari

  • The Lok Sabha has passed the “Promotion and Regulation of Online Gaming Bill, 2025,” which imposes a blanket ban on all online games involving money, regardless of skill or chance.
  • This legislation, combined with the earlier 28% GST on the full face value, signals a clear stance against the RMG sector, A INR 2 lakh crore industry.
  • The regulatory and tax changes have put the future of India’s real money gaming industry at a critical stage, forcing companies to pivot or face potential collapse.

Exencial Industry Tidings 21/08/2025

By Viral Kishorchandra Shah

  • Floriculture industry’s sales decline by 43.8% in June 2025 quarter
  • India takes urgent steps to secure urea supply amid surge in demand
  • Plastic films & flexible packaging industry’s sales grow by 9% in June 2025 quarter

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Dian Swastatika Sentosa, Daiichi Sankyo, Pop Mart, Shibaura Electronics, Kawasaki Heavy Industries, Ryohin Keikaku, First Pacific Co, Samsung Life Insurance and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Dian Swastatika Sentosa (DSSA IJ): Surprise, Surprise!
  • Daiichi Sankyo Placement – US$1.2bn Deal but Momentum Isn’t the Best, Last Deal Didn’t Do Well
  • Hang Seng Indexes: Announcement Tomorrow; Potential Changes & Updated Flows
  • [Japan M&A] Minebea Matches YAGEO for Shibaura Elec (6957) At ¥6,200. Presses on Early Cashout
  • [Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Kawasaki Heavy (7012 JP)
  • [Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Ryohin Keikaku (7453 JP)
  • First Pacific (142 HK) Is Fully Valued Here
  • True Aspect (Trade-Wise) Of the Samsung Life Accounting Issue: Today’s Biggest Market Narrative
  • Japanese Retailer Red Alert Is the Reddest Ever
  • Shibaura Electronics (6957 JP): Yageo Goes All in with a JPY6,635 Offer


Dian Swastatika Sentosa (DSSA IJ): Surprise, Surprise!

By Brian Freitas

  • Dian Swastatika Sentosa (DSSA IJ) will be added to a global index in August and that should come as a surprise to most of the market.
  • The stock is up 10x over the last 18 months and liquidity has shown a marked improvement in the last year.
  • Dian Swastatika Sentosa (DSSA IJ) trades at nosebleed valuations and there is the risk of a sell off following index inclusion.

Daiichi Sankyo Placement – US$1.2bn Deal but Momentum Isn’t the Best, Last Deal Didn’t Do Well

By Sumeet Singh

  • A group of shareholders are looking to raise up to US$1.2bn via selling most of their stake in Daiichi Sankyo (4568 JP) .
  • While the deal shouldn’t come as a surprise, given the ongoing cross-shareholding unwind,  the last deal in the stock didn’t do well.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Hang Seng Indexes: Announcement Tomorrow; Potential Changes & Updated Flows

By Brian Freitas


[Japan M&A] Minebea Matches YAGEO for Shibaura Elec (6957) At ¥6,200. Presses on Early Cashout

By Travis Lundy

  • After three months of NOT matching YAGEO’s bid for Shibaura Electronics (6957 JP) at ¥6,w00 as YAGEO’s proposal continues its long plod through FEFTA review, Minebea-Mitsumi has now matched ¥6,200.
  • Key is that their bid closes before the indicative deadline for YAGEO to receive word on FEFTA approval. They are hoping this bid mollifies the irrevocables and everyone else. 
  • But if YAGEO cares, it could bump to ¥6,300 tomorrow and extend its tender offer which closes on Monday. But the put option is now struck higher, which de-risks this.

[Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Kawasaki Heavy (7012 JP)

By Travis Lundy

  • On 26 August at the close, 2 names will get added to and 5 names deleted from a global index provider’s major Japan/global “standard” index.
  • 6 of 7 changes were in the Quiddity Index predictions as of end Jun-2025. One dropped, then two got added. Our final predictions had all seven plus one more DEL.
  • These changes were well-flagged so well pre-positioned. This insight looks at shareholder structure, historical fundamental ratios, and performance vs Peers. Watch the direct peers.

[Quiddity Index] August Global Index Japan ADDs – Differing Peer Dynamics – Ryohin Keikaku (7453 JP)

By Travis Lundy

  • On 26 August at the close, 2 names will get added to and 5 names deleted from a global index provider’s major Japan/global “standard” index.
  • 6 of 7 changes were in the Quiddity Index predictions as of end Jun-2025. One dropped, then two got added. Our final predictions had all seven plus one more DEL.
  • They were well-flagged so well pre-positioned. This insight looks at shareholder structure, historical fundamental ratios, and performance vs Peers. This sets up a possible trade before or into the event.

First Pacific (142 HK) Is Fully Valued Here

By David Blennerhassett


True Aspect (Trade-Wise) Of the Samsung Life Accounting Issue: Today’s Biggest Market Narrative

By Sanghyun Park

  • Both accounting issues are complex, but intense regulator scrutiny fuels the Samsung Life Act case, sparking governance reshuffle bets and driving today’s Samsung Life stock pop.
  • Accounting rechecks could spark divestment fears or governance-driven rerating, creating a classic headline-driven, bidirectional trading setup.
  • Near-Term, this is a headline-driven momentum setup: Samsung Life longs/shorts, ready to pivot, with relative-value plays vs financial peers or Samsung’s governance-linked names.

Japanese Retailer Red Alert Is the Reddest Ever

By Michael Allen

  • Japan maybe facing an unprecedented heat wave this fall, threatening retailers’ profits as high-end seasonal items may not sell 
  • Six major retailers, including Fast Retailing, are at risk of serious profit declines if the weather forecasts are accurate. That’s a big “IF”, but wait, there’s more.
  • U.S. tariffs on clothing could devastate Fast Retailing’s profits there, potentially forcing them to withdraw from the U.S. market.  

Shibaura Electronics (6957 JP): Yageo Goes All in with a JPY6,635 Offer

By Arun George

  • In response to Minebea Mitsumi (6479 JP) matching its Shibaura Electronics (6957 JP) offer on 14 August, Yageo Corporation (2327 TT) increased its offer by 7.0% from JPY6,200 to JPY6,635.  
  • To remain in the game, Yageo had to bump. The latest bump underscores Yageo’s confidence in securing regulatory approvals. 
  • The Minebea CEO suggested that its JPY6,200 offer would be the final one. If Yageo secures regulatory approval (likely), Minebea will walk rather than match Yageo’s latest offer. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Health Care: Myungin Pharmaceutical, Wuxi Biologics, EpimAb Biotherapeutics, Jiangsu Hengrui Pharmaceuticals, Halozyme Therapeutics, Novo Nordisk A/S, TuHURA Biosciences, Bridgebio Pharma Inc, Masimo Corp, Henry Schein and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Myungin Pharmaceutical IPO Preview
  • Wuxi Biologics (2269 HK): Expanded Offering and Capacity Drive 1H25 Result; Accelerated Growth Ahead
  • EpimAb (岸迈生物) Pre-IPO: Differentiated Bispecific Products
  • Jiangsu Hengrui (1276 HK): Robust 1H25; Innovative Drugs Key; Out-Licensing Affirm Pipeline Strength
  • Halozyme Therapeutics: ENHANZE Platform Expansion & Critical Factors That Will Define Its Success in 2025 and Beyond!
  • Novo Nordisk & GoodRx Shake Up Drug Pricing: Ozempic At $499 Sends Shockwaves!
  • HURA: IFx-2.0 Phase III Begins
  • BridgeBio Pharmaceuticals: Initiation Of Coverage- A Closer Look At Its Scientific Advancements & Pipeline Developments!
  • Masimo Corporation Unveils Next-Gen Root Monitor; Can Its Innovations Help Grap A Larger Pie Of The Market?
  • Henry Schein: Growing Profits With BOLD+1 & Smart Partnerships & Key Developments!


Myungin Pharmaceutical IPO Preview

By Douglas Kim

  • Myungin Pharmaceutical is getting ready to complete its IPO in KOSPI in September. The IPO price range is from 45,000 won to 58,000 won. 
  • The total offering amount ranges from 153 billion won ($111 million) to 197 billion won ($143 million). The book building for the institutional investors lasts from 9 to 15 September. 
  • Using EBITDA of 104.5 billion won and EV/EBITDA of 7.9x and IPO discount ranges of 32.2% to 47.4%, this resulted in IPO price range of 45,000 won to 58,000 won. 

Wuxi Biologics (2269 HK): Expanded Offering and Capacity Drive 1H25 Result; Accelerated Growth Ahead

By Tina Banerjee

  • Wuxi Biologics (2269 HK) logged solid performance in 1H25, with revenue growing 16% YoY to RMB10B and net profit increasing 55% YoY to RMB3B. Revenue from continuing operations grew 20%.
  • Total backlog reached $20B as of June 30, 2025, including $11B service backlog, while the total backlog within three years stood at $4B, enhancing near-term revenue visibility.
  • The company raised 2025 revenue growth target to 14–16% YoY from 12–15% YoY earlier. This indicates 2H25 revenue to be RMB11,524M, up 14% YoY and 16% HoH.

EpimAb (岸迈生物) Pre-IPO: Differentiated Bispecific Products

By Ke Yan, CFA, FRM

  • EpimAb, a China-based clinical stage biotech company, is looking to raise at least USD 100 million via a Hong Kong listing. CITIC Securities and CMBI are the joint sponsors.
  • In this note, we look at the company’s product pipeline, its pre-IPO investors, and management.
  • Our initial view is that the company does provide a line-up of differentiated products though still in early stage of clinical development.

Jiangsu Hengrui (1276 HK): Robust 1H25; Innovative Drugs Key; Out-Licensing Affirm Pipeline Strength

By Tina Banerjee

  • In 1H25, Jiangsu Hengrui reported 16% YoY increase in revenue to RMB 15.8B primarily attributable to the growth of innovative drugs sales along with increase in licensing revenue.
  • R&D expenses surged 6% to RMB 3.2B due to ongoing clinical trials. Net profit increased 30% YoY to RMB 4.5B resulting in net margin expanding 310bps to 28.3% in 1H25.
  • In 1H25, the company obtained marketing approvals for six Class 1 innovative drugs, including trastuzumab rezetecan injection (as second line of treatment for NSCLC with HER2 mutations).

Halozyme Therapeutics: ENHANZE Platform Expansion & Critical Factors That Will Define Its Success in 2025 and Beyond!

By Baptista Research

  • Halozyme Therapeutics, Inc. reported its second quarter 2025 financial results, marking a period of robust growth.
  • The company announced a 41% increase in total revenue, reaching $326 million, driven primarily by strong royalty revenue, which saw a 65% year-over-year rise to $206 million.
  • The growth is attributed to the continued performance of blockbuster subcutaneous therapies such as DARZALEX, Phesgo, and VYVGART Hytrulo, which are enhanced by Halozyme’s ENHANZE technology.

Novo Nordisk & GoodRx Shake Up Drug Pricing: Ozempic At $499 Sends Shockwaves!

By Baptista Research

  • Novo Nordisk has taken a bold step in reshaping the U.S. pharmaceutical landscape by partnering with GoodRx to offer its blockbuster Type 2 diabetes drug, Ozempic, directly to consumers at $499 per month—about half its traditional list price.
  • Announced in mid-August 2025, the move mirrors the company’s earlier direct-to-consumer strategy for Wegovy, its obesity drug, and is designed to capture uninsured or underinsured patients struggling with access.
  • While Novo says that 98% of insured patients already have coverage for Ozempic, the new program aims to expand access to those outside the system through Novo’s own telehealth storefront and GoodRx’s nationwide pharmacy network.

HURA: IFx-2.0 Phase III Begins

By Zacks Small Cap Research

  • TuHURA is a clinical-stage, oncology-focused biotechnology company advancing innate immune agonists, checkpoint inhibitors & antibody-drug conjugates (ADCs).
  • It offers the IFx platform technology featuring the IFx-2.0 tumoral injection delivery approach for Merkel cell carcinoma (MCC) & the IFx-3.0 intravenous delivery approach for lymphoma.
  • IFx encodes a bacterial protein to be expressed in cancer cells, activating the innate immune system & subsequent cascade that may eliminate the tumor.

BridgeBio Pharmaceuticals: Initiation Of Coverage- A Closer Look At Its Scientific Advancements & Pipeline Developments!

By Baptista Research

  • BridgeBio Pharma delivered strong second-quarter results, emphasizing significant progress in both its commercial operations and pipeline development.
  • The company’s lead product, Attruby, used in the treatment of ATTR cardiomyopathy, exhibited robust growth.
  • In Q2 2025, Attruby generated $78 million in global sales, with $71.5 million from U.S. net sales, reflecting 100% growth over the previous quarter.

Masimo Corporation Unveils Next-Gen Root Monitor; Can Its Innovations Help Grap A Larger Pie Of The Market?

By Baptista Research

  • Masimo Corporation’s second quarter of 2025 presents a mixed yet interesting picture for potential investors, focusing predominantly on the healthcare technology sector while strategizing significant organizational and operational shifts.
  • The quarter reflected growth in core areas but faced challenges in others, encapsulated by both strategic initiatives and external disruptions.
  • On the positive side, Masimo reported continued strength in its healthcare business, with revenue reaching $370 million, marking a 7.4% increase on a constant currency basis.

Henry Schein: Growing Profits With BOLD+1 & Smart Partnerships & Key Developments!

By Baptista Research

  • Henry Schein, Inc. presents a complex outlook as its second quarter 2025 performance demonstrates both challenges and opportunities.
  • The company’s global sales reached $3.2 billion, growing by 3.3% from the previous year, though impacted by various challenges such as reduced U.S. distribution margins primarily due to lower glove pricing and targeted sales initiatives.
  • This quarter also saw a 42 basis point drop in GAAP operating margins and a 79 basis point decline on a non-GAAP basis, attributed to decreases in gross margins and increased operational costs.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars